#20: Comparing 2 cryoballoons for ablation of paroxysmal atrial fibrillation, a high-risk subpopulation for transcatheter aortic valve replacement, hypertensive disorders in pregnancy

#20: Comparing 2 cryoballoons for ablation of paroxysmal atrial fibrillation, a high-risk subpopulation for transcatheter aortic valve replacement, hypertensive disorders in pregnancy

In this episode of Cardiology Digest, we dive into top journals like JAMA Cardiology to bring you three of the most compelling recent research papers from the field of cardiology.

STUDY #1: First, see how the new Boston Scientific cryoballoon measures up against Medtronic's product. Did the newcomer outshine the veteran, or does it come with hidden risks? Discover the head-to-head results and what they mean for the future of atrial fibrillation cryoablation.

Reichlin, T, Kueffer, T, Knecht, S et al. 2024. PolarX vs Arctic Front for cryoballoon ablation of paroxysmal AF: The randomized COMPARE CRYO study. JACC Clin Electrophysiol. In Press, Corrected Proof. (https://doi.org/10.1016/j.jacep.2024.03.021)

STUDY #2: Next, we explore the intersection of aging, aortic stenosis, and osteosarcopenia in elderly patients undergoing transcatheter aortic valve replacement. This study highlights a radiographic method that reveals a high-risk subpopulation within this demographic. See how this insight can shape our approach to transcatheter aortic valve replacement, and what it means for patient care strategies.

Solla-Suarez, P, Arif, S, Ahmad, F, et al. 2024. Osteosarcopenia and mortality in older adults undergoing transcatheter aortic valve replacement. JAMA Cardiol. 7: 611-618. (https://doi.org/10.1001/jamacardio.2024.0911)

O'Gara, P, Guduguntla, V, Bonow, R, et al. 2024, Osteosarcopenia and mortality after transcatheter aortic valve replacement. JAMA Cardiol. 7: 618-619. (https://doi.org/10.1001/jamacardio.2024.1018)

STUDY #3: Finally, we turn our attention to the pressing issue of hypertensive disorders in pregnancy. Discover why close postpartum monitoring is critical and what the latest research suggests about the persistence of hypertension in new mothers. Could longer follow-ups hold the key to better postpartum care?

Hauspurg, A, Venkatakrishnan, K, Collins, L, et al. 2024. Postpartum ambulatory blood pressure patterns following new-onset hypertensive disorders of pregnancy. JAMA Cardiol. Published online (https://doi.org/10.1001/jamacardio.2024.1389)

Join us to unravel these important studies and their implications for your practice and patients. Ready to stay ahead in the rapidly evolving world of cardiology? Hit play and let's get started!

Learn more with Medmastery's courses:

Holter Monitoring Essentials (2 CME)

Get a Basic or Pro account, or, get a Trial account.

Show notes:

Visit us at https://www.medmastery.com/podcasts/cardiology-podcast.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(25)

#25: Influenza and myocardial infarction, fasting protocols for cath lab procedures, anticoagulation therapy and transcatheter aortic-valve replacement

#25: Influenza and myocardial infarction, fasting protocols for cath lab procedures, anticoagulation therapy and transcatheter aortic-valve replacement

In today's episode of Cardiology Digest, we look at three recent research papers that can impact your clinical practice. They're from NEJM Evidence, the European Heart Journal, and The New England Jou...

8 Okt 202410min

#24: Patient selection and antiplatelet therapy for percutaneous coronary intervention (PCI), the best anticoagulants for patients with atrial fibrillation

#24: Patient selection and antiplatelet therapy for percutaneous coronary intervention (PCI), the best anticoagulants for patients with atrial fibrillation

In this episode of Medmastery's Cardiology Digest, we dive into three groundbreaking studies that are set to reshape our understanding and approach to cardiology. STUDY #1: First, we discuss a landmar...

24 Sep 202411min

#23: Edoxaban dosage and atrial fibrillation, invasive vs. noninvasive treatment of NSTEMI, chelation therapy for coronary artery disease

#23: Edoxaban dosage and atrial fibrillation, invasive vs. noninvasive treatment of NSTEMI, chelation therapy for coronary artery disease

Stay ahead with the newest cardiology research findings that could change your clinical practice! STUDY #1: First up, we explore new data on edoxaban dosage for older patients with atrial fibrillation...

10 Sep 202410min

#22: Heart failure & rapid uptitration of neurohormonal blockade, home treatment for acute pulmonary embolism, cardiovascular outcomes after bariatric surgery for weight loss

#22: Heart failure & rapid uptitration of neurohormonal blockade, home treatment for acute pulmonary embolism, cardiovascular outcomes after bariatric surgery for weight loss

Welcome to the latest episode of Medmastery's Cardiology Digest, where In less than 15 minutes we'll get you up to date on breakthrough studies and advancements in cardiology that can impact your clin...

27 Aug 202412min

#21: Semaglutide and blindness, antihypertensive medications and eczematous dermatitis, the new PREVENT cardiovascular risk calculator

#21: Semaglutide and blindness, antihypertensive medications and eczematous dermatitis, the new PREVENT cardiovascular risk calculator

This week, we have three compelling research papers that are sure to expand your clinical acumen. STUDY #1: We explore the debate surrounding the new PREVENT calculator's impact on predictions of 10-y...

13 Aug 202412min

#19:  Coffee's impact on blood pressure, safety of carotid artery stenting in the real world, transcatheter aortic-valve replacement in patients with coronary artery disease

#19: Coffee's impact on blood pressure, safety of carotid artery stenting in the real world, transcatheter aortic-valve replacement in patients with coronary artery disease

Ready to dig into the latest cardiology research? In less than 15 minutes, we'll give you the low-down on three new studies that'll help you in clinical practice. STUDY #1: First, we explore safety ou...

16 Jul 202410min

#18: CHA2DS2-VASc scoring and anticoagulation for silent atrial fibrillation, race and renin-angiotensin system inhibition in HFrEF, V142I transthyretin gene variant and cardiovascular health

#18: CHA2DS2-VASc scoring and anticoagulation for silent atrial fibrillation, race and renin-angiotensin system inhibition in HFrEF, V142I transthyretin gene variant and cardiovascular health

In less than 15 minutes, Medmastery's Cardiology Digest will give you the low-down on some of the most compelling studies in cardiology that clinicians with an interest in cardiovascular health need t...

2 Jul 202412min

Populært innen Vitenskap

fastlegen
liberal-halvtime
jss
romkapsel
tingenes-tilstand
sinnsyn
forskningno
rss-paradigmepodden
fjellsportpodden
rekommandert
villmarksliv
vett-og-vitenskap-med-gaute-einevoll
dekodet-2
rss-rekommandert
tidlose-historier
rss-lundqvist-podden
rss-alt-forklart-for-barn
hva-er-greia-med
diagnose
nevropodden